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The article is devoted to investigation of coordination compounds of palladium (II) with 3-(2-
pyridyl)-1,2,4-triazole derivatives containing amino groups. We syntesized 4 ligands and 4 new 
coordination compounds. An interesting after removing of BOC-protection, NH2-group is still 
uncoordinated. In 1H NMR spectra of complexes was a significant shift of the ortho-pyridine proton 
in a low-field area, which prove proposed structure. This may be due to its closeness to the lone 
electron pair of the nitrogen cycle of the second triazole ligand. 
________________________________________________________________________________ 
Introduction 
Heterocyclic ligands play an important 
role in the development of coordination 
chemistry. Amongst available five-membered 
ring systems, triazoles represent an interesting 
class of compounds due to the presence of three 
nitrogens [1-3]. 1,2,4-Triazole derivatives show 
diverse pharmacological activities and have 
been examined as antitumor [4], antibacterial 
[5], antifungal [6] and antiviral agents [7]. 
Metal complexes containing triazole 
may also show biological activity, providing an 
impetus for the investigation of their 
coordination chemistry [8-10]. 
Complexes of 3-(2-pyridyl)-1,2,4-
triazoles typically have high stability, owing to 
the mutual combination of σ-donor and π-
acceptor properties. If to compare electronic 
properties of 3-(2-pyridile)-1,2,4-triazolyl 
moiety with such wide used ligand as 2,2`-
bypyridine, the first one is stronger σ-donor and 
weaker π-acceptor [11]. Also it should be noted 
that deprotonation of triazole ring arranges 
triazole containing ligands to act as a charged 
bidentate, or even tridentate ligands with 
simultaneous enhancing of complex stability.  
Substantial amount of research has been 
dedicated to the study of noble metal complexes 
which incorporate derivatives of 1,2,4-triazole. 
This is due to their interesting photophysical 
and photochemical properties. Another possible 
use of these complexes is as catalysts in 
different chemical reactions. For example, 
palladium complexes can be used in cross-
coupling reactions in preparative organic 
chemistry, as well as in obtaining of materials 
with luminescent properties [1-3]. 
Results and discussion 
The synthesis of ligands 3 are based on 
acylation of 2 by iminoester 1 with 
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subsequent cyclization of the resulting 
amidrazones into 1,2,4-triazoles (Scheme 1). 
Deprotection of 3 in acidic conditions leads to 
formation of amines 4. The attempts to obtain 6 
directly from ligands were unsuccessful, 
because of palladium reduction. Therefore we 
have synthesized palladium complexes 5 using 
BOC protected amines. Deprotection of 5 with 
TFA leads to obtaining of title compounds. 
 The absence of a 1H NMR signal for the 
proton connected to the triazol ring, indicates 
the deprotonated form of ligands in 5 and 6. It is 
noteworthy that the chemical shift of the ortho-
Py proton in 5a and 5b are 9.54 and 9.35 ppm 
respectively, i.e. this proton becomes less 
shielded compared to the free ligand 
(Δδ5a=+0.91 ppm, Δδ5b=+0.71).  
Deprotection of 5 with TFA leads to 
formation of trifluoroacetates of title 
compounds 6. TFA was used for this purpose 
instead of HCl, because reaction with latter 
results in PdCl2 formation. Changes in 
1H 
NMR-spectra of 6 comparing to free ligands is 
of the same character as in 5. Δδ For ortho-Py 
proton in 6a and 6b is +0.94 and +0.85 ppm 
respectively. These could be realized in the 
structure proposed for 5 and 6 (Fig.1), where 
the ortho-Py proton is situated in a deshielded 
region formed by a triazole ring of an opposite 
ligand molecule, which is an accordance with 
previously obtained compounds [12].  
Conclusion  
This article describes synthesis and 
characterization of four novel palladium (II) 
complex containing 3-(2-pyridyl)-1,2,4-triazole 
moiety. Two of them were obtained by 
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Fig.1. Schematic illustration of  5 and 6 structure. 
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deprotection of amino groups in corresponding 
complexes. The structure of title compounds 
was proved by means of 1H NMR spectroscopy. 
Experimental part 
Elemental analyses were carried out at 
Perkin-Elmer"2400"CHN Analyzer. NMR 
spectra in DMSO-d6 solution were recorded on 
a Varian"400"spectrometer at room 
temperature. 
General procedure A (3a,b): 10 ml of sodium 
methoxide methanolic solution (35 wt%) was 
added to solution of 1 (0.05 mol)  in 20 ml of 
methanol and stirred at room temperature for 1 
hour. Then 2 was added to obtained iminoester 
solution and refluxed for 10 hours. Obtained 
mixture was cooled to room temperature and 
solvent removed in vacuo. The resulting 
suspension was diluted with water and acidified 
with 2 ml of acetic acid to obtain a white solid. 
The crystals were separated via filtration, dried 
and recrystalized from toluene. 
3-(2-pyridyl)-5-Boc-methylamino-1,2,4-triazole 
(3a): 6.26 g, (62.0%), white crystals. 1H NMR 
(DMSO-d6, 400 MHz): dH(ppm) 14.72–14.50 
(br s, 1 H), 8.62 (d, 1 H), 8.11 (m, 1 H), 7.97 
(m, 1 H), 7.47 (d, 1 H), 7.15 (br s, 1 H), 4.26 (s, 
2 H), 1.39 (s, 9 H). Anal. calсd. for C13H17N5O2, 
%: C,56.71; H,6.22; N,25.44. Found: C,56.98; 
H,6.15; N,25.88. 
3-(2-pyridyl-4-methyl)-5-Boc-isopropylamine-
1,2,4-triazole (3b): 6.88 g, (69%), white 
crystals. 1H NMR (DMSO-d6, 400 MHz): 
dH(ppm) 14.81–14.66 (br s,1 H), 8.69 (d, 1 H), 
8.06 (d, 1 H), 7.52 (s, 1 H), 7.09 (br s, 1 H), 
4.29 (s, 1 H), 2.35 (s, 3 H) 1.42 (d, 3 H), 1.34 (s, 
9 H).  Anal. calсd. for C15H21N5O2, %: C,59.39; 
H,6.98; N,23.09. Found: C,59.52; H,6.58; 
N,23.44. 
 General procedure B (4a,b): 0.9 ml of 
hydrochloric acid (3.00M) was added to 
solution of 3 (0.03 mol) in 50 ml of 
isopropanole and refluxed for 24 h. Solvent was 
removed under vacuo to obtain a white crystals 
of 4. 
3-(2-pyridyl)-5-methylamino-1,2,4-triazole 
(4a): 5.01 g, (92.0%), white crystals. 1H NMR 
(DMSO-d6, 400 MHz): dH(ppm) 15.10–14.85 
(br s, 1 H), 8.78 (br s, 3 H), 8.71 (d, 1 H), 8.06-
7.97 (m, 2 H), 7.54 (d, 1 H), 4.13 (s, 2 H). Anal. 
calсd. for C8H10ClN5O2, %: C,45.40; H,4.76; 
N,33.09. Found: C,45.88; H,4.62; N,33.23. 
3-(2-pyridyl-4-methyl)-5-isopropylamine-1,2,4-
triazole (4b): 4,93 g, (89%), white crystals. 1H 
NMR (DMSO-d6, 400 MHz): dH(ppm) 14.85–
14.61 (br s, 1 H), 8.79 (s, 3 H), 8.66 (s, 1 H), 
8.02-7.92 (m, 2 H), 4.16 (s, 1 H), 2.53 (m, 3 H), 
1.49 (d, 3 H). Anal. calсd. for C10H14ClN5, %: 
C,50.11; H,5.89; N,29.22. Found: C,50.48; 
H,5.75; N,29.53. 
General procedure C (5a,b): PdCl2×(CH3CN)2 
(0.26 g, 1 mmol) in hot acetonitrile (20 mL) was 
added to solution of 3 (2 mmol) and Et3N (0.29 
ml, 2 mmol) in acetonitrile (20 ml). Precipitated 
yellow crystals were collected by filtration, 
washed with acetonitrile and dried in air. 
5a: 1H NMR (DMSO-d6, 400 MHz): dH(ppm) 
9.54 (d, 2 H), 8.54 (m, 2 H), 7.96 (m, 2 H), 7.58 
(d, 2 H), 4.69 (s, 4 H), 1.49 (s, 18 H). Anal. 
calсd. for C26H32N10O4Pd, %: C,53.44; H, 4.28; 
N,22.44. Found: C,53.82; H,4.54; N,22.19. 
5b: 1H NMR (DMSO-d6, 400 MHz): dH(ppm) 
9.35 (s, 2 H), 7.96-7.58 (m, 4 H), 4.19 (s, 2 H), 
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2.61 (d, 6 H), 1.57 (s, 6 H), 1.42 (s, 18 H). Anal. 
calсd. For C30H40N10O4Pd, %: C,50.67; H, 5.68; 
N,19.71. Found: C,50.82; H,5.59; N,19.33. 
General procedure D (6a,b). Solution of 1 
mmol TFA in DCM was added to suspension of 
5 (0,5 mmol) in 20 ml of DCM and then 
refluxed for 2 h. The mixture was then cooled to 
room temperature and the solvent was removed 
to obtain light yellow crystals of 6.  
6a: 1H NMR (DMSO-d6, 400 MHz): dH(ppm) 
9.71 (d, 2 H), 8.56 (m, 2 H), 7.97 (m, 2 H), 7.61 
(d, 2 H), 4.72 (s, 4 H). Anal. calсd. for 
C20H18F6N10O4Pd, %: C,35.18; H,2.66; N,20.51. 
Found: C,34.98; H,2.54; N,20.69. 
6b: 1H NMR (DMSO-d6, 400 MHz): dH(ppm) 
9.64 (d, 2 H), 8.58 (s, 4 H), 7.86 (m, 2 H), 7.52 
(d, 2 H), 4.63 (s, 2 H), 2.57 (s, 6 H), 1.67 (d, 6 
H). Anal. calсd. for C20H25N10Pd, %: C,39.01; 
H, 3.55; N,18.96. Found: C,38.72; H,3.84; 
N,18.55. 
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